Introduction & Update on Human Cryopreservation with Dr.Emil Kendziorra

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/21/3b/be/213bbe66-7a8c-3a5d-7011-96f9be64b323/mza_1747005262675932524.jpg/600x600bb.jpg

VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA

VitaDAO

35 episodes

6 days ago

Our core mission is the acceleration of research and development (R&D) in the longevity space and the extension of human life and healthspan. To achieve this, VitaDAO collectively funds and digitizes research in the form of IP-NFTs. 👉vitadao.com

Technology

RSS

All content for VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA is the property of VitaDAO and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Technology

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/15308511/15308511-1638803549740-47bc81d2de916.jpg

Introduction & Update on Human Cryopreservation with Dr.Emil Kendziorra

VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA

30 minutes 19 seconds

2 years ago

Introduction & Update on Human Cryopreservation with Dr.Emil Kendziorra

Dr. Emil Kendziorra is a founder and CEO at Tomorrow Biostasis GmbH based in Berlin, Germany and President of the Board at European Biostasis Foundation, a non-profit research foundation in Switzerland.

00:00 Intro
03:50 What is “Cryopreservation”?
06:58 State of Technology
13:00 When and why opt for “Cryopreservation”?
17:12 Important considerations
20:03 What does Tomorrow Biostasis do?
22:15 CryoDAO
22:55 What we are looking for?
23:35 The impact of getting involved in Cryopreservation
24:27 Q&A